# A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (EUROLIGHT) (EUROLIGHT)

> **NCT06351605** · — · RECRUITING · sponsor: **LumiThera, Inc.** · enrollment: 500 (estimated)

## Conditions studied

- Dry Age-related Macular Degeneration

## Interventions

- **DEVICE:** Valeda Light Delivery System

## Key facts

- **NCT ID:** NCT06351605
- **Lead sponsor:** LumiThera, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2026-09
- **Final completion:** 2026-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06351605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06351605, "A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (EUROLIGHT) (EUROLIGHT)". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06351605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*